Tryfonopoulos D, Anastasiou E, Protogerou A, Papaioannou T, Lily K, Dagre A, Souvatzoglou E, Papamichael C, Alevizaki M, Lekakis J
Department of Clinical Therapeutics, Alexandra University Hospital, Athens, Greece.
J Endocrinol Invest. 2005 Jul-Aug;28(7):616-22. doi: 10.1007/BF03347260.
The aim of our study was to measure arterial stiffness in patients with Type 1 diabetes mellitus, its contributing factors and its relation to macrovascular arterial changes.
Thirty-one female Type 1 diabetic patients were studied; 11 had concomitant autoimmune thyroid disease although euthyroid during the study period. Stiffness was studied using applanation tonometry and pulse wave analysis for evaluation of systolic arterial pressure augmentation secondary to arterial stiffening and early wave reflection. Results were compared to 24 healthy individuals. In all patients, endothelium-related flow-mediated dilation (FMD) of the brachial artery and intima-media thickness (IMT) of the carotid artery were measured.
Augmentation pressure (AP) and augmentation index (AI) were higher in Type 1 diabetic patients suggesting stiffer arteries compared to controls (AP: 5.8 +/- 3.6 vs 2.8 +/- 2.2 mmHg, p < 0.001; and AI:18.3 +/- 9 vs 11.1 +/- 8.8%, p = 0.004). The subgroup of diabetic patients with autoimmune thyroid disease presented stiffer arteries than those without (AP: 6.5 +/- 2.9 vs 5.5 +/- 3.9 mmHg, p < 0.05; and AI: 21.3 +/- 5.4 vs 16.7 +/- 10.3%, p < 0.05), though the two groups did not differ statistically by means of age, disease duration, hemoglobin A1c (HbA1c), lipid levels, FMD and IMT. In multiple regression analysis, variables independently associated to AI in the diabetes group were: age (p = 0.028), IMT of the carotid artery bifurcation (p = 0.045), disease duration (p = 0.031) and autoimmune thyroid disease (p = 0.015). No correlation was observed between AI and metabolic control, blood pressure, microalbuminuria, presence of retinopathy and endothelial function (FMD).
Women with Type 1 diabetes have increased arterial stiffness, which indicates macroangiopathy. An independent correlation between these indices and carotid IMT was observed. Concomitant autoimmune thyroid disease seems to aggravate arterial compliance in these patients, a finding that merits further investigation.
本研究旨在测量1型糖尿病患者的动脉僵硬度、其影响因素及其与大血管动脉病变的关系。
对31例1型糖尿病女性患者进行研究;其中11例在研究期间伴有自身免疫性甲状腺疾病,尽管甲状腺功能正常。采用压平式眼压测量法和脉搏波分析来研究僵硬度,以评估动脉僵硬度和早期波反射导致的收缩期动脉压升高。将结果与24名健康个体进行比较。对所有患者测量肱动脉的内皮相关血流介导的舒张功能(FMD)和颈动脉的内膜中层厚度(IMT)。
1型糖尿病患者的增压压(AP)和增压指数(AI)高于对照组,提示动脉僵硬度更高(AP:5.8±3.6 vs 2.8±2.2 mmHg,p<0.001;AI:18.3±9 vs 11.1±8.8%,p = 0.004)。伴有自身免疫性甲状腺疾病的糖尿病患者亚组的动脉僵硬度高于无该疾病的患者(AP:6.5±2.9 vs 5.5±3.9 mmHg,p<0.05;AI:21.3±5.4 vs 16.7±10.3%,p<0.05),尽管两组在年龄、病程、糖化血红蛋白(HbA1c)、血脂水平、FMD和IMT方面无统计学差异。在多元回归分析中,糖尿病组中与AI独立相关的变量为:年龄(p = 0.028)、颈动脉分叉处的IMT(p = 0.045)、病程(p = 0.031)和自身免疫性甲状腺疾病(p = 0.015)。未观察到AI与代谢控制、血压、微量白蛋白尿、视网膜病变的存在及内皮功能(FMD)之间的相关性。
1型糖尿病女性的动脉僵硬度增加,这表明存在大血管病变。观察到这些指标与颈动脉IMT之间存在独立相关性。伴有自身免疫性甲状腺疾病似乎会加重这些患者的动脉顺应性,这一发现值得进一步研究。